WinstonWınston
Drägerwerk AG & Co. KGaA logo

Drägerwerk AG & Co. KGaA

DRW3.DE
52
Medical - Devices · Healthcare
Also trades as: 0MT8.L
Price
€111.60
+0.20 (+0.18%)
Market Cap
€2.09B
Exchange
Frankfurt Stock Exchange
Winston Score
52
Winston is curious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 13, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Mixed
Growth
Good
Cash Flow
Strong
Stability
Exceptional
Valuation
Strong
Dividends
Strong

Winston Score History

The full picture

Drägerwerk is a German company that makes safety and medical equipment. Its core products include breathing devices, gas detection systems, anesthesia machines, and patient monitoring equipment. It sells to hospitals, fire departments, industrial facilities, and emergency services around the world — and has been doing so for over 130 years.

The company earns money by selling hardware, software, and related services, including maintenance contracts that provide recurring revenue. Dräger operates globally, with a strong presence in Europe, the Americas, and Asia, and generates roughly €3 billion in annual revenue. Its long history and specialized certifications create switching costs, since hospitals and industrial customers rarely change safety-critical suppliers. The main risk is that Dräger operates in a highly competitive market with thin operating margins, and its complex corporate structure — a partnership limited by shares — gives the founding family significant control, which can limit shareholder influence over strategic decisions.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+8.6% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+161.7% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$319M/ year

Flat (-4% vs prior year)

9.2% of revenue

Below sector average (18%)

Steady R&D investment year-over-year

Insider Activity

2.0%ownership

Flat

Insider ownership roughly steady over the past year

Cash Runway

~23 months

$199M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Adequate runway but may need to raise capital within 2 years

Growth context

Drägerwerk AG & Co. KGaA is growing revenue at 9% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Share count broadly stable

0.1% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 18.8M (2021) → 18.7M (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
46.6%
Healthy — 46.6% gross margin
Operating Margin
5.4%
Thin — 5.4% operating margin
ROCE
2.4%
Weak — 2.4% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+6.4%
Slow sales growth (+6.4% YoY)
EPS YoY
+72.1%
Earnings growing fast (+72.1% YoY)

Earnings growing 25%+ a year. The compounder zone.

EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
164%
Turns 164% of profit into real cash
FCF Margin
5.3%
Thin free cash flow (5.3%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.14
Conservative — low debt load (0.14)
Interest Cover
9.78x
Comfortably covers interest (9.8x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
12.2x
Attractive valuation — P/E 12.2

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

P/E vs Forward
+1.7
GROWING
Earnings expected to grow — slightly cheaper on forward P/E

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
2.06%
Moderate income — 2.06% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend Growth
+727.6%
Dividend growing fast (727.6% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial